Literature DB >> 12843044

Comparison of two commercial enzyme-linked immunosorbent assays with an immunofluorescence assay for detection of Legionella pneumophila types 1 to 6.

Annette K Malan1, Thomas B Martins, Troy D Jaskowski, Harry R Hill, Christine M Litwin.   

Abstract

Members of the genus Legionella are characterized as gram-negative, motile, freshwater-dwelling bacteria that were responsible for a pneumonia outbreak among American Legion members in 1976. Because clinicians routinely order serologic testing for Legionella pneumophila serogroups 1 to 6 as a screen for possible L. pneumophila infections, we evaluated the Wampole Laboratories L. pneumophila type 1 to 6 immunoglobulin G (IgG) and IgM combined enzyme-linked immunosorbent assay (ELISA) and the Zeus Scientific L. pneumophila type 1 to 6 IgG-IgM-IgA multispecific combined ELISA systems and compared them to an IgG-specific immunofluorescence assay (IFA) for L. pneumophila serogroups 1 to 6. The Centers for Disease Control and Prevention recommends that the positive titer cutoff for an IFA be 1:256. Regardless of where the positive IFA cutoff titer is placed, however, the sensitivity of both commercial assays was below what would be acceptable for a screening assay. With a 1:256 IFA titer as the positive cutoff, the agreement, sensitivity, and specificity of the Wampole ELISA were 74.6, 21.4, and 98.4%, respectively. The agreement, sensitivity, and specificity of the Zeus ELISA were 72.6, 10.5, and 100.0%, respectively. We recommend that any laboratories attempting to replace an IFA type 1 to 6 screen with an alternative ELISA carefully investigate the sensitivity of the replacement assay.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12843044      PMCID: PMC165279          DOI: 10.1128/JCM.41.7.3060-3063.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Legionella drozanskii sp. nov., Legionella rowbothamii sp. nov. and Legionella fallonii sp. nov.: three unusual new Legionella species.

Authors:  A A Adeleke; B S Fields; R F Benson; M I Daneshvar; J M Pruckler; R M Ratcliff; T G Harrison; R S Weyant; R J Birtles; D Raoult; M A Halablab
Journal:  Int J Syst Evol Microbiol       Date:  2001-05       Impact factor: 2.747

2.  Further development of simple tests to differentiate the legionellas.

Authors:  G Vesey; P J Dennis; J V Lee; A A West
Journal:  J Appl Bacteriol       Date:  1988-10

3.  Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group.

Authors:  J F Plouffe; T M File; R F Breiman; B A Hackman; S J Salstrom; B J Marston; B S Fields
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

4.  Legionella pneumonia in the United States: the distribution of serogroups and species causing human illness.

Authors:  A L Reingold; B M Thomason; B J Brake; L Thacker; H W Wilkinson; J N Kuritsky
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

5.  Legionella gresilensis sp. nov. and Legionella beliardensis sp. nov., isolated from water in France.

Authors:  F Lo Presti; S Riffard; H Meugnier; M Reyrolle; Y Lasne; P A Grimont; F Grimont; R F Benson; D J Brenner; A G Steigerwalt; J Etienne; J Freney
Journal:  Int J Syst Evol Microbiol       Date:  2001-11       Impact factor: 2.747

6.  Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality.

Authors:  B J Marston; H B Lipman; R F Breiman
Journal:  Arch Intern Med       Date:  1994-11-14

Review 7.  Legionella and Legionnaires' disease: 25 years of investigation.

Authors:  Barry S Fields; Robert F Benson; Richard E Besser
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

8.  Legionnaires' disease: description of an epidemic of pneumonia.

Authors:  D W Fraser; T R Tsai; W Orenstein; W E Parkin; H J Beecham; R G Sharrar; J Harris; G F Mallison; S M Martin; J E McDade; C C Shepard; P S Brachman
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

9.  Legionella taurinensis sp. nov., a new species antigenically similar to Legionella spiritensis.

Authors:  F Lo Presti; S Riffard; H Meugnier; M Reyrolle; Y Lasne; P A Grimont; F Grimont; F Vandenesch; J Etienne; J Fleurette; J Freney
Journal:  Int J Syst Bacteriol       Date:  1999-04

10.  Legionnaires' disease: clinical features of the epidemic in Philadelphia.

Authors:  T F Tsai; D R Finn; B D Plikaytis; W McCauley; S M Martin; D W Fraser
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

View more
  5 in total

1.  Comparison and evaluation of four commercial kits relative to an in-house immunofluorescence test for detection of antibodies against Legionella pneumophila.

Authors:  P Elverdal; C S Jørgensen; S A Uldum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11-09       Impact factor: 3.267

2.  Evaluation of Vircell enzyme-linked immunosorbent assay and indirect immunofluorescence assay for detection of antibodies against Legionella pneumophila.

Authors:  Bram M W Diederen; Jan A J W Kluytmans; Marcel F Peeters
Journal:  Clin Vaccine Immunol       Date:  2006-03

3.  Vircell assays for detection of antibodies against Legionella pneumophila.

Authors:  Almudena Rojas; José Rojas; Joaquín Mendoza
Journal:  Clin Vaccine Immunol       Date:  2007-02

4.  Rainfall is a risk factor for sporadic cases of Legionella pneumophila pneumonia.

Authors:  Carolina Garcia-Vidal; Maria Labori; Diego Viasus; Antonella Simonetti; Dolors Garcia-Somoza; Jordi Dorca; Francesc Gudiol; Jordi Carratalà
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

5.  Nanosensor dosimetry of mouse blood proteins after exposure to ionizing radiation.

Authors:  Dokyoon Kim; Francesco Marchetti; Zuxiong Chen; Sasa Zaric; Robert J Wilson; Drew A Hall; Richard S Gaster; Jung-Rok Lee; Junyi Wang; Sebastian J Osterfeld; Heng Yu; Robert M White; William F Blakely; Leif E Peterson; Sandhya Bhatnagar; Brandon Mannion; Serena Tseng; Kristen Roth; Matthew Coleman; Antoine M Snijders; Andrew J Wyrobek; Shan X Wang
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.